New smallpox vaccines for an ancient scourge
Abstract
The potential use of variola virus, a Class A agent of bioterrorism, remains a concern. In an effort to prepare for a possible smallpox outbreak due to an intentional release of variola, the U.S. government and industry have been evaluating vaccines stored in the National Strategic Stockpile including cell culture grown ACAM2000 and modified vaccinia Ankara, IMVAMUNE, in clinical studies. This paper discusses smallpox vaccines studies conducted at the Saint Louis University Center for Vaccine Development.
Similar articles
-
Clinical guidance for smallpox vaccine use in a postevent vaccination program.MMWR Recomm Rep. 2015 Feb 20;64(RR-02):1-26. MMWR Recomm Rep. 2015. PMID: 25695372
-
ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Drug Des Devel Ther. 2010 May 25;4:71-9. doi: 10.2147/dddt.s3687. Drug Des Devel Ther. 2010. PMID: 20531961 Free PMC article. Review.
-
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.N Engl J Med. 2019 Nov 14;381(20):1897-1908. doi: 10.1056/NEJMoa1817307. N Engl J Med. 2019. PMID: 31722150 Clinical Trial.
-
The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.Expert Rev Vaccines. 2009 Jul;8(7):841-50. doi: 10.1586/erv.09.55. Expert Rev Vaccines. 2009. PMID: 19538111 Review.
-
Research continues on new vaccines and biologics at the Saint Louis University Center for Vaccine Development.Mo Med. 2014 Jul-Aug;111(4):320. Mo Med. 2014. PMID: 25211861 Free PMC article. No abstract available.
Cited by
-
Current status of next-generation vaccines against mpox virus: a scoping review.Front Pharmacol. 2025 Apr 28;16:1533533. doi: 10.3389/fphar.2025.1533533. eCollection 2025. Front Pharmacol. 2025. PMID: 40356988 Free PMC article. Review.
-
Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission.One Health. 2022 Dec;15:100410. doi: 10.1016/j.onehlt.2022.100410. Epub 2022 Jun 24. One Health. 2022. PMID: 36249992 Free PMC article.
-
Monkeypox virus vaccine evolution and global preparedness for vaccination.Int Immunopharmacol. 2022 Dec;113(Pt A):109346. doi: 10.1016/j.intimp.2022.109346. Epub 2022 Oct 20. Int Immunopharmacol. 2022. PMID: 36274490 Free PMC article.
-
Monkeypox Virus Infections in Humans.Clin Microbiol Rev. 2022 Dec 21;35(4):e0009222. doi: 10.1128/cmr.00092-22. Epub 2022 Nov 14. Clin Microbiol Rev. 2022. PMID: 36374082 Free PMC article. Review.
-
Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.Heliyon. 2024 May 18;10(10):e31490. doi: 10.1016/j.heliyon.2024.e31490. eCollection 2024 May 30. Heliyon. 2024. PMID: 38826712 Free PMC article.
References
-
- World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec. 1980;55:145–52.
-
- Henderson DA. The Looming Threat of Bioterrorism. Science. 1999;283:1279–82. - PubMed
-
- Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva, Switzerland: World health Organization; 1988.
-
- Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis. 1970;122:303–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical